The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
i think more a demonstration of extreme frustration Mafuta...the science is useless unless the board can engage and do a deal, as the patent click continues ticking i just see peek year sales being lost...as others have said if the science is that good we would not be sat with a collapsing share price...experts like politicians, judge by actions not words...thats the harsh reality of this...there have been a number of mis steps which were unnecessary and too many distractions...i am knee deep in this and the only saving factor is the collapse might force some better discipline on the people that have taken us down this road...
We are with you on that...fingers crossed...
well the hand picked experienced consultants screwed that up....what a s*** show...the BoD needs to consider whether the right people are in charge...running around after HNWIs was not the way to proceed, just as the share consolidation, management time needs to be spent in value add not value destruction...I am loosing patience...
well they have jobs posted so I guess so...
I would say it much more strongly, I think the board are screwing it up...the patent clock already started...so we loose time for peak year sales. The HNWs were a distraction from the job of serious business development and engagement with the main players. Just how long can the can be kicked down the road for. Yes I am feeling very frustrated and the board are way too comfortable with them selves. Like I said before never saw need for consolidation at all where are all the big promised investors...its more distraction on management in getting the products out. I am seriously loosing it at the moment with this...
Interesting article repeating what other have said in last week... https://www.barrons.com/articles/big-pharma-mergers-biotech-cash-51651844327
A waiting game for many...
and still waiting for all those big investors that needed a consolidated share price....total and absolute b********* . Just wasting management time and distraction...as i have said before the BOD need some critical friends to kick ass as they are simply too comfortable with each other...
Generally dissappointed and felt was all pretty unprofessional, they need some media training....waste of time listening...expect big tumble in price on consolidation...everythjng is jam tomorrow and Sierra are not rushing anything for Tims sake...
Its a no from me...little point and just money and time spent for what...complete distraction from what should be the focus which is getting the dam science out protected and licensed...I am unconvinced by the arguments presented for consolidation.
Am getting frustrated I have to say...so with the HNWIs why give the introducer a bung, might as well have a rights issue or further raise via primary bid either way no free lunch. Just a move to redistribute wealth either way.
Why focus on HNWIs better surely spend time on pharma, seems mis directed effort to me.
They must be using one of the slowest medical writers to generate this tox report...normally consultants falling over themselves do stuff quickly....there seems little urgency in any of this whilst the patent clock ticks down...
The science may be great but I am less clear about the decision making...
and before somebody accuses me of trolling I have been in the industry and this is not following a normal course for what ever reason...lets hope that the behind the scenes is very different from what is being observed and i can only judge on what I see which is sloath like speed...and lots of distractions
I want somebody to get a grip and focus please !!!! Am waiting for the flames...but it is how I feel and just laying it out as I see it.
Hi Zylo
Was not complaining about the return I hold 4.5+ million across personal and company accounts. Bought more upto the 9p peak. My PrimaryBid holding was very small.
But my issue is with speed and challenge. I also have 20 years in pharma behind me. The patent is like a starting pistol for most as each year delay is a loss of 12 months peak sales. It usually has a stronger motivating effect on progression.
I have worked with driven teams that were very good with limited resource and time.
We may not see the full picture but its an open question to me at the moment which I cannot answer by what I have seen and heard so far. All plausible all may be OK but there is something I feel slowing things up. Gut feel...whatever...
chrs...Nubex
Got to say as a shareholder that came in with PrimaryBid i can see the progress but the board is kicking the can down the road so too speak...alot of stuff is contracted and they can speed some of this up....the Agile decision should have been made months ago...Sierra may yet sit on their hands and may be too poor to make the milestone payments....there is alot of stuff that has just been left hanging or delayed for no reason i can see....i think the BOD are too comfortable with each other and some clean skin challengers are needed to ask the right questions....as for consolidations I have never had one work in my favour ever ....I actually think its the wrong time for the board too consolidate...and maybe in 12 to 24 months better....as many funds looks at market cap...not how many shares they get....apart from all that heres hoping for a startling 2022....best wishes all....
Well if we get to a 1 GBP how about the Baur au Lac in Zurich for a meet for all....but @Thoth2 can we end up their before Langstrasse ;)...10 GBP might have to be The Dolder Grand...that would reduce my companies tax burden significantly...this really is a high speed rollercoaster